RESUMEN
BACKGROUND/AIMS: It has been proposed that preeclampsia is a metabolic syndrome of pregnancy. The polymorphisms PstI and MaeIII of INS, NsiI of INSR and Ala513Pro and Gly972Arg of IRS1 have been associated with metabolic syndrome; moreover, the products of these genes are functionally contiguous during insulin signaling. The aim of this study was to assess whether these polymorphisms are associated with preeclampsia. METHODS: 46 normotensive pregnant women and 43 preeclamptic patients were included in the study to develop a clinical, biochemical and genotypic profile of preeclampsia. Clinical evaluation consisted of measurement of blood pressure, height and weight. Peripheral blood samples were collected for determination of fasting glucose and insulin concentrations and for extraction of genomic DNA. Proteinuria was determined. Polymorphisms were detected using PCR-RFLP. RESULTS: The normotensive and preeclampsia groups did not differ significantly in clinical and biochemical traits, except for systolic and diastolic blood pressure (p < 0.0001). Polymorphisms previously associated with metabolic syndrome in Mexican populations were not associated with preeclampsia in Mexican women (p > 0.05). CONCLUSION: The lack of an association between preeclampsia and the polymorphisms studied suggests that other genes whose products do not have direct functional interaction with metabolic syndrome or epigenetic factors may play a role in preeclampsia.
Asunto(s)
Proteínas Sustrato del Receptor de Insulina/genética , Insulina/genética , Preeclampsia/genética , Receptor de Insulina/genética , Adulto , Alelos , Glucemia/metabolismo , Presión Sanguínea/fisiología , Estudios Transversales , ADN/genética , ADN/metabolismo , Femenino , Haplotipos , Humanos , Insulina/sangre , Proteínas Sustrato del Receptor de Insulina/sangre , México , Reacción en Cadena de la Polimerasa , Polimorfismo de Longitud del Fragmento de Restricción , Polimorfismo de Nucleótido Simple , Preeclampsia/sangre , Embarazo , Receptor de Insulina/sangre , Adulto JovenRESUMEN
INTRODUCTION: Hemoglobin disorders are classified into three main groups: structural variants, thalassemias (thal) and hereditary persistence of fetal hemoglobin (HPFH). OBJECTIVE. This study describes the types and frequencies of hemoglobinopathies from four states of the Pacific coast of Mexico (Jalisco, Colima, Nayarit and Michoacan). MATERIAL AND METHODS. We studied 1513 Mexican individuals by hematological and biochemical analysis following the conventional methods, DNA analysis was carried out in abnormal samples. RESULTS. The frequency of hemoglobinopathies was 1.258%. Structural variants were the most common type (0.726%), with seven carriers (0.462%) and one homozygote (0.066%) for Hb S, and three heterozygotes of the following hemoglobins: C (beta6 Glu-->Lys), Fannin-Lubbock I (beta119 Gly-->Asp) and Colima (beta49 Ser-->Cys), with a frequency of 0.066% each. We observed a frequency of 0.466% for the thalassemia group, with one homozygote for the alpha3.7 (-thal) allele (0.066%), and 6 heterozygotes for beta-thal (0.40%), with the allele IVS1:110 G-->A in three subjects, and the alleles Cd 39, IVS1:5 G-->A and -28 A-->C in the three other. HPFH was detected in one subject (0.066%). Jalisco and Colima had the highest frequencies of hemoglobinopathies, 3.015% and 1.331% respectively, and the latter showed the most diversity of hemoglobin disorders. CONCLUSIONS: The observed heterogeneity of types and frequencies of hemoglobinopathies in the regions studied illustrate the importance of further investigation of these abnormalities in Mexico.
Asunto(s)
Hemoglobinopatías/clasificación , Hemoglobinopatías/epidemiología , Humanos , MéxicoRESUMEN
Objetivo. Identificar con técnicas de biología molecular, los de Ó-Thal en poblaciones hospitalarias seleccionadas. Métodos. Diez y ocho propositi con datos hematológicos y bioquímicos sugestivos de talasemia-Ó, seleccionados de 356 pacientes con probable hemoglobinopatía provenientes de cuatro hospitales de dos ciudades, se investigaron para seis alelos comunes de talasemia-Ó. Los estudios moleculares se realizaron por reacción en cadena de la polimerasa y digestión con enzimas de restricción específicas. Resultados. El alelo Ó se identificó en dos casos: el estudio familiar mostró el mismo alelo en la madre de ambos y se detectó además heterocigocidad para HbS en uno de ellos. El análisis con Apa I reveló en ambos pacientes la deleción clase I que es el alelo más comúnmente observado en el mundo. Este estudio mostró 2/356 (0.6 por ciento) de portadores Ó, una frecuencia baja comparada con la observada en otras poblaciones del mundo. La ausencia de los otros alelos sugiere que en México la talasemia-Ó es molecularmente tan heterogénea como la talasemia-ß